Hexal Pharma Ag opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Hexal Pharma Ag

Patent Number:
Title:
A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation
Opposition Date:
May 14, 2020
Patent Number:
Title:
Crenolanib For Treating Flt3 Mutated Proliferative Disorders
Opposition Date:
Dec 7, 2018

Competitors of Hexal Pharma Ag

AROG PHARMACEUTICALS, INC.

EURO-CELTIQUE S.A.

Want to track Hexal Pharma Ag?

Feel free to send us a message here and we will get back to you